Grace Therapeutics, Inc. (GRCE) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $71.99M | -1.8% |
| 2024 | $73.30M | -7.4% |
| 2023 | $79.12M | -38.5% |
| 2022 | $128.62M | +105.9% |
| 2021 | $62.46M | +173.3% |
| 2020 | $22.85M | -38.1% |
| 2019 | $36.90M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $71.99M | -1.8% |
| 2024 | $73.30M | -7.4% |
| 2023 | $79.12M | -38.5% |
| 2022 | $128.62M | +105.9% |
| 2021 | $62.46M | +173.3% |
| 2020 | $22.85M | -38.1% |
| 2019 | $36.90M | — |